清热利湿除痹汤联合温针灸治疗湿热痹阻型类风湿关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.6;R593.22

基金项目:

河南省重点研发与推广专项计划(2023YD10208)


Clinical Study on Qingre Lishi Chubi Decoction Combined with Warm Acupuncture in Treating Rheumatoid Arthritis of Damp-Heat Obstruction Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清热利湿除痹汤联合温针灸治疗湿热痹阻型类风湿关节炎的临床疗效及其对血清巨噬细胞集落刺激因子(GM-CSF)、免疫功能的影响。方法:选择2023年1月—2024年2月鹤壁市中医院治疗的135例类风湿关节炎患者,采用随机数字表法分为温针灸组、中药组、针药联合组各45例。经剔除后最终温针灸组纳入44例、中药组43例、针药联合组43例。温针灸组给予温针灸治疗,中药组给予清热利湿除痹汤治疗,针药联合组给予温针灸联合清热利湿除痹汤治疗。疗程均为12周。比较3组临床疗效和不良反应发生情况、中医证候评分、关节超声表现评分、6 点行为评分(BRS-6)、28 个关节疾病活动评分(DAS-28)、CD4+ T、CD8+ T、含免疫球蛋白和免疫受体酪氧酸抑制基序(ITIM) 结构域的T细胞免疫受体(TIGIT)、血清肿瘤坏死因子-α (TNF-α)、GM-CSF、活性氧(ROS) 水平。结果: 治疗后, 针药联合组总有效率为97.67% (42/43), 中药组为88.37% (38/43), 温针灸组为84.09% (37/44), 3 组比较, 差异有统计学意义(P<0.05)。治疗后,3组关节肿痛、关节发热、口渴、晨僵、发热、关节屈伸不利、汗出等中医证候评分均较治疗前降低(P<0.05);3组各项评分比较,差异均有统计学意义(P<0.05),其中针药联合组评分低于中药组、温针灸组(P<0.05),中药组评分低于温针灸组(P<0.05)。治疗后,3组超声表现、DAS-28、BRS-6评分较治疗前降低(P<0.05);3组超声表现、DAS-28、BRS-6评分比较,差异均有统计学意义(P<0.05),其中针药联合组3项评分低于温针灸组、中药组(P<0.05),中药组3项评分低于温针灸组(P<0.05)。治疗后,3 组CD4+、TIGIT 水平均较治疗前降低(P<0.05),CD8+水平均较治疗前升高(P<0.05);其中针药联合组CD4+、TIGIT水平均低于温针灸组、中药组(P<0.05),CD8+水平高于温针灸组、中药组(P<0.05);中药组CD4+、TIGIT 水平均低于温针灸组(P<0.05),CD8+水平高于温针灸组(P<0.05)。治疗后,3 组TNF-α、GM-CSF、ROS 水平较治疗前降低(P<0.05);其中针药联合组3 项指标水平低于温针灸组、中药组(P<0.05),中药组3项指标水平低于温针灸组(P<0.05)。针药联合组不良反应发生率为16.28%(7/43),温针灸组为11.36%(5/44),中药组为9.30% (4/43),3组比较,差异无统计学意义(P>0.05)。治疗期间,3组患者肝肾功能、血常规、尿常规均无明显异常。结论:清热利湿除痹汤联合温针灸治疗湿热痹阻型类风湿关节炎可有效调节机体免疫应答,抑制炎症反应及下调活性氧水平,改善关节超声表现,缓解关节症状,疗效优于单用清热利湿除痹汤或温针灸治疗。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Qingre Lishi Chubi Decoction combined with warm acupuncture in treating rheumatoid arthritis (RA) of damp-heat obstruction type and its effects on serum granulocytemacrophage colony-stimulating factor (GM-CSF) and immune function. Methods:A total of 135 RA patients treated in Hebi Hospital of Chinese Medicine from January 2023 to February 2024 were enrolled and randomly divided into the warm acupuncture group, the Chinese medicine group, and the acupuncture-medicine combination group by the random number table method,with 45 cases in each group. After exclusions,44 cases in the warm acupuncture group, 43 cases in the Chinese medicine group, and 43 cases in the acupuncture-medicine combination group were finally included. The warm acupuncture group received warm acupuncture;the Chinese medicine group received Qingre Lishi Chubi Decoction;and the acupuncture-medicine combination group received both warm acupuncture and Qingre Lishi Chubi Decoction. All groups were treated for 12 weeks. The clinical efficacy, incidence of adverse reactions, traditional Chinese medicine (TCM) syndrome scores, ultrasonographic finding scores, 6-point Behavioral Rating Scale( BRS-6) scores,28-joint Disease Activity Score( DAS-28) scores,CD4+ T cell and CD8+ T cell levels,T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT) expression, and serum levels of tumor necrosis factor-α (TNF-α), GM-CSF, and reactive oxygen species (ROS) were compared among the three groups. Results:After treatment,the total effective rate was 97.67% (42/43) in the acupuncture-medicine combination group,88.37% (38/43) in the Chinese medicine group,and 84.09% (37/44) in the warm acupuncture group,the difference being significant among the three groups (P<0.05). After treatment,the TCM syndrome scores (joint swelling and pain,joint fever,thirst,morning stiffness,fever,limited joint flexion and extension, sweating) in all three groups were decreased when compared with those before treatment (P<0.05); comparison of all scores among the three groups showed statistically significant differences (P<0.05). with the scores in the acupuncture-medicine combination group being lower than those in the Chinese medicine group and the warm acupuncture group (P<0.05), and the scores in the Chinese medicine group being lower than those in the warm acupuncture group (P<0.05). After treatment,the ultrasonographic finding,DAS-28,and BRS-6 scores in all three groups were decreased when compared with those before treatment (P<0.05);comparison of ultrasound findings scores DAS-28 scores,and BRS-6 scores among the three groups showed statistically significant differences (P<0.05),with the three scores in the acupuncture-medicine combination group being lower than those in the warm acupuncture group and the Chinese medicine group (P<0.05),and the three scores in the Chinese medicine group being lower than those in the warm acupuncture group (P<0.05). After treatment, the levels of CD4+ T cells and TIGIT in all three groups were decreased when compared with those before treatment (P<0.05), while the levels of CD8+ T cells were increased (P<0.05). The levels of CD4+ T cells and TIGIT in the acupuncture-medicine combination group were lower than those in the warm acupuncture group and the Chinese medicine group (P<0.05),while the CD8+ T cell level was higher (P<0.05). The levels of CD4+ T cells and TIGIT in the Chinese medicine group were lower than those in the warm acupuncture group (P<0.05),while the CD8+ T cell level was higher (P<0.05). After treatment,the levels of TNF-α,GM-CSF,and ROS in all three groups were decreased when compared with those before treatment (P< 0.05); the three indicators in the acupuncture-medicine combination group were lower than those in the warm acupuncture group and the Chinese medicine group (P<0.05), and those in the Chinese medicine group were lower than those in the warm acupuncture group (P<0.05). The incidence of adverse reactions was 16.28% (7/43) in the acupuncture-medicine combination group,11.36% (5/44) in the warm acupuncture group,and 9.30% (4/43) in the Chinese medicine group,there being no significant difference among the three groups (P>0.05). During treatment,no significant abnormalities were observed in liver and kidney function, blood routine, or urine routine tests across the three groups. Conclusion: Qingre Lishi Chubi Decoction combined with warm acupuncture can effectively regulate immune responses, inhibit inflammatory reactions and reactive oxygen species levels, improve ultrasonographic findings, and alleviate joint symptoms in RA patients of damp-heat obstruction type, with superior effect to either Qingre Lishi Chubi Decoction or warm acupuncture alone.

    参考文献
    相似文献
    引证文献
引用本文

张义,张蔚蓉,武海波.清热利湿除痹汤联合温针灸治疗湿热痹阻型类风湿关节炎临床研究[J].新中医,2026,58(20):21-27

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-10-21
  • 出版日期:
文章二维码